The Washington Post just published an article about Dupuytren disease mentioning the Dupuytren Research Group and two of its directors, Gary Pess MD and Charles Eaton MD.
https://www.washingtonpost.com/wellness/2022/11/20/dupuytrens-crippling-hand-disease-treatments/
Progress toward a Dupuytren

I want to share three exciting Dupuytren updates with you this Halloween.
The first update is the growing use of artificial intelligence (AI) in medical research. The term “Artificial Intelligence” is

The path to a Dupuytren cure is connected to the story of drugs for rheumatoid arthritis. The evolution of rheumatoid drug treatment dates back centuries, based on guesswork and trial